Scorecards so far?
Harry, 8. Good and unbiased summation. ERM took strategic business steps to take a strong shareholding and apply influence over the progress of their investment in EGO. Also cutting their obligation to fund J/V expenses. I don't hear them complaining.
Pinnacle, - 2. Still got your plonker up I see? Your version of history is somewhat conveniently biased perhaps?
What you say about all the shareholder honking is old rope and now irrelevant. The second 249d would also have failed if ERM didnt take it on. They did back the change of control, and partly funded the process as well.
Times are tough overall, but ERM are still in there and no doubt acutely interested in progress as it occurrs. From a business perspective it is probably unremarkable that the interests of ERM, would prevail over yours and mine. That doesn't make them the bad guy.
I have moved on, but you? Well I enjoy a good joke as much as the next guy. Thanks for jumping in.
PB your initial score is 5 for the tribute to good old Ahjay, Wabbit and I, but you have been docked -3 for being completely irrelevant. And a further -2 for being a spectator, and not a player. As usual nothing meaningful from you yet.
Anyone else?
The real problem is ?
- Forums
- ASX - By Stock
- EGO
- So who is the problem?
So who is the problem?, page-10
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EGO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online